SCHEMBL3423264

SCHEMBL3423264

CN(C)NP(O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trimethylammonium SCHEMBL27269293 0.59
Trimethylammonium SCHEMBL27269292 0.59
SCHEMBL27461493 0.56
SCHEMBL1393593 0.56
SCHEMBL21549 0.56
SCHEMBL10041774 0.56
SCHEMBL9579047 0.53
SCHEMBL10337203 0.50
Dimethylamine SCHEMBL11616562 0.49
SCHEMBL29026238 0.49

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12472267-B2 Compositions containing nucleic acid nanoparticles with modular functionality Sixfold Bioscience Ltd. (GB) 2025-11-18 US disclosed
US-20230183746-A1 COMPOSITIONS FOR TRANSFER OF CARGO TO CELLS Sixfold Bioscience Ltd. (GB) 2023-06-15 US disclosed
CN-115997016-A Composition comprising nucleic acid nanoparticles having modular functional groups 西克斯福德生物科学有限公司 2023-04-21 CN disclosed
EP-4143316-A2 COMPOSITIONS CONTAINING NUCLEIC ACID NANOPARTICLES WITH MODULAR FUNCTIONALITY Sixfold Bioscience Ltd. (GB) 2023-03-08 EP disclosed
US-20220370635-A1 COMPOSITIONS CONTAINING NUCLEIC ACID NANOPARTICLES WITH MODULAR FUNCTIONALITY SIXFOLD BIOSCIENCE LTD (GB) 2022-11-24 US disclosed
EP-4022058-A2 COMPOSITIONS FOR TRANSFER OF CARGO TO CELLS Sixfold Bioscience Ltd. (GB) 2022-07-06 EP disclosed
US-11357865-B2 Compositions containing nucleic acid nanoparticles with modular functionality Sixfold Bioscience Ltd. (GB) 2022-06-14 US disclosed
WO-2021220053-A2 COMPOSITIONS CONTAINING NUCLEIC ACID NANOPARTICLES WITH MODULAR FUNCTIONALITY Sixfold Bioscience Ltd. (GB) 2021-11-04 WO disclosed
US-20210330810-A1 COMPOSITIONS CONTAINING NUCLEIC ACID NANOPARTICLES WITH MODULAR FUNCTIONALITY Sixfold Bioscience Ltd. (GB) 2021-10-28 US disclosed
US-20180258427-A1 MODIFIED iRNA AGENTS BANK OF AMERICA, N.A. 2018-09-13 US disclosed
EP-0270651-A1 NOVEL DEOXYRIBONUCLEOSIDE PHOSPHORAMIDITES AND THEIR USE FOR THE PREPARATION OF OLIGONUCLEOTIDES. CALIFORNIA INST OF TECHN (US) 1988-06-15 EP disclosed
US-4734491-A DNA sequences encoding hybrid lymphoblastoid-leukocyte human interferons UNIVERSITY PATENTS, INC. (US) 1988-03-29 US disclosed
US-4728609-A Recombinant growth hormone releasing factor HOFFMANN-LA-ROCHE INC. (US) 1988-03-01 US disclosed
WO-1988000201-A1 NOVEL DEOXYRIBONUCLEOSIDE PHOSPHORAMIDITES AND THEIR USE FOR THE PREPARATION OF OLIGONUCLEOTIDES CALIFORNIA INSTITUTE OF TECHNOLOGY, INC. (US) 1988-01-14 WO disclosed
EP-0173935-A1 Hybrid lymphoblastoid-leukocyte human interferons UNIVERSITY PATENTS, INC. (US) 1986-03-12 EP disclosed
US-4517338-A SOLID PHASE SYNTHESIS, TUBULAR REACTOR CHIRON CORPORATION (US) 1985-05-14 US disclosed
US-4483964-A AGITATION OF REAGENTS BY PRESSURIZATION TUBAL REACTOR CHIRON CORPORATION (US) 1984-11-20 US disclosed
EP-0119621-A1 Interleukin-2 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1984-09-26 EP disclosed
EP-0108387-A1 Preparation of recombinant growth releasing factors F. HOFFMANN-LA ROCHE AG (CH) 1984-05-16 EP disclosed
EP-0090789-A1 Chemical DNA synthesis MONSANTO COMPANY (US) 1983-10-05 EP disclosed